BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1375716)

  • 1. Analysis of phosphotyrosine-containing proteins present in v-src-infected myeloid progenitor cells.
    Erwin JL; Anderson SM
    Oncogene; 1992 Jun; 7(6):1101-7. PubMed ID: 1375716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors.
    Chang JH; Wilson LK; Moyers JS; Zhang K; Parsons SJ
    Oncogene; 1993 Apr; 8(4):959-67. PubMed ID: 7681161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a tyrosine kinase activity with GAP complexes in v-src transformed fibroblasts.
    Pronk GJ; Polakis P; Wong G; de Vries-Smits AM; Bos JL; McCormick F
    Oncogene; 1992 Feb; 7(2):389-94. PubMed ID: 1549356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
    Ellis C; Moran M; McCormick F; Pawson T
    Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src.
    Lau AF
    Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.
    Kamps MP; Sefton BM
    Oncogene; 1988 Apr; 2(4):305-15. PubMed ID: 2452398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype.
    Krüger A; Anderson SM
    Oncogene; 1991 Feb; 6(2):245-56. PubMed ID: 1705687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src.
    Akiho H; Tokumitsu Y; Noda M; Nomura Y
    Arch Biochem Biophys; 1993 Jul; 304(1):235-41. PubMed ID: 7686735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium induces tyrosine phosphorylation of a novel p120GAP-associated protein of 65 kDa.
    Medema JP; de Vries-Smits AM; Bos JL
    Oncogene; 1995 Aug; 11(4):757-62. PubMed ID: 7544452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.
    Pronk GJ; de Vries-Smits AM; Ellis C; Bos JL
    Oncogene; 1993 Oct; 8(10):2773-80. PubMed ID: 8378086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
    Maroney AC; Qureshi SA; Foster DA; Brugge JS
    Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
    Yoshinaka Y; Katoh I; Kyushiki H; Sakamoto Y
    Exp Cell Res; 1995 Jul; 219(1):21-8. PubMed ID: 7543053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A target for Src in mitosis.
    Fumagalli S; Totty NF; Hsuan JJ; Courtneidge SA
    Nature; 1994 Apr; 368(6474):871-4. PubMed ID: 7512695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of v-Src transformation in primary rat embryo fibroblasts.
    Inoue H; Tavoloni N; Hanafusa H
    Oncogene; 1995 Jul; 11(2):231-8. PubMed ID: 7624140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
    Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
    Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck.
    Ellis C; Liu XQ; Anderson D; Abraham N; Veillette A; Pawson T
    Oncogene; 1991 Jun; 6(6):895-901. PubMed ID: 1906156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of a gap junction protein correlates with inhibition of cell-to-cell communication.
    Filson AJ; Azarnia R; Beyer EC; Loewenstein WR; Brugge JS
    Cell Growth Differ; 1990 Dec; 1(12):661-8. PubMed ID: 1963075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate.
    Lock P; Abram CL; Gibson T; Courtneidge SA
    EMBO J; 1998 Aug; 17(15):4346-57. PubMed ID: 9687503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.